Zeria Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Cash & Equivalents	22,652	23,592	20,323	16,219	11,704	9,793	Upgrade
Short-Term Investments	-	-	-	-	-	3	Upgrade
Cash & Short-Term Investments	22,652	23,592	20,323	16,219	11,704	9,796	Upgrade
Cash Growth	-7.01%	16.09%	25.30%	38.58%	19.48%	8.78%	Upgrade
Receivables	24,846	26,611	21,080	17,419	16,153	13,497	Upgrade
Inventory	19,649	16,433	14,489	12,764	11,950	11,104	Upgrade
Other Current Assets	2,862	2,893	1,917	1,801	1,856	2,916	Upgrade
Total Current Assets	70,009	69,529	57,809	48,203	41,663	37,313	Upgrade
Property, Plant & Equipment	26,800	26,641	26,517	24,591	23,139	23,634	Upgrade
Long-Term Investments	22,909	22,541	22,957	20,172	18,165	18,775	Upgrade
Goodwill	3,294	3,621	4,262	5,299	5,830	6,429	Upgrade
Other Intangible Assets	35,723	36,740	38,877	36,631	35,376	35,640	Upgrade
Long-Term Deferred Tax Assets	-	97	110	136	108	67	Upgrade
Other Long-Term Assets	1	2	1	2	1	1	Upgrade
Total Assets	158,736	159,171	150,533	135,034	124,282	121,859	Upgrade
Accounts Payable	5,072	3,971	3,273	1,996	2,049	1,693	Upgrade
Accrued Expenses	1,176	1,623	1,584	1,554	1,530	1,268	Upgrade
Short-Term Debt	34,326	34,298	38,283	34,890	33,842	44,158	Upgrade
Current Income Taxes Payable	3,468	3,773	1,967	749	458	562	Upgrade
Other Current Liabilities	9,379	10,784	9,411	7,969	6,314	6,076	Upgrade
Total Current Liabilities	53,421	54,449	54,518	47,158	44,193	53,757	Upgrade
Long-Term Debt	5,515	6,865	7,943	14,541	18,385	5,819	Upgrade
Pension & Post-Retirement Benefits	261	224	458	234	1,073	1,308	Upgrade
Long-Term Deferred Tax Liabilities	-	6,496	6,447	5,190	3,905	3,356	Upgrade
Other Long-Term Liabilities	7,731	1,341	1,339	2,232	1,635	1,441	Upgrade
Total Liabilities	66,928	69,375	70,705	69,355	69,191	65,681	Upgrade
Common Stock	6,593	6,593	6,593	6,593	6,593	6,593	Upgrade
Additional Paid-In Capital	9,664	11,685	11,685	11,685	11,685	11,685	Upgrade
Retained Earnings	67,886	67,207	59,254	53,462	48,860	46,380	Upgrade
Treasury Stock	-16,245	-18,266	-18,265	-18,264	-17,593	-14,997	Upgrade
Comprehensive Income & Other	23,772	22,320	20,355	11,973	5,349	6,350	Upgrade
Total Common Equity	91,670	89,539	79,622	65,449	54,894	56,011	Upgrade
Minority Interest	138	257	206	230	197	167	Upgrade
Shareholders' Equity	91,808	89,796	79,828	65,679	55,091	56,178	Upgrade
Total Liabilities & Equity	158,736	159,171	150,533	135,034	124,282	121,859	Upgrade
Total Debt	39,841	41,163	46,226	49,431	52,227	49,977	Upgrade
Net Cash (Debt)	-17,189	-17,571	-25,903	-33,212	-40,523	-40,181	Upgrade
Net Cash Per Share	-389.95	-398.62	-587.64	-751.86	-897.74	-872.14	Upgrade
Filing Date Shares Outstanding	44.08	44.08	44.08	44.08	44.21	45.36	Upgrade
Total Common Shares Outstanding	44.08	44.08	44.08	44.08	44.41	45.7	Upgrade
Working Capital	16,588	15,080	3,291	1,045	-2,530	-16,444	Upgrade
Book Value Per Share	2079.65	2031.31	1806.31	1484.77	1236.08	1225.66	Upgrade
Tangible Book Value	52,653	49,178	36,483	23,519	13,688	13,942	Upgrade
Tangible Book Value Per Share	1194.50	1115.67	827.66	533.55	308.22	305.09	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.